NOX-FLO™

• NOX-FLO™ contains the clinically validated rutinosides Hesperidin 2S and Diosmin citrus flavonoids with antioxidant, venotonic, and inflammation-modulating properties.*
• NOX-FLO™ also contains Citrulline, CoEnzyme Q10, and R-Lipoic Acid, shown in extensive research to enhance nitric oxide (NO) synthesis and improve NO-dependent endothelial function and vasodilation.*
• NOX-FLO's™ proprietary blend of safe ingredients is powered by Tesseract’s unparalleled bioavailability science, which enables micro-dose delivery of these clinically validated nutrients.
  
  − Why Tesseract’s NOX-FLO™? This ground-breaking formula combines the therapeutic benefits of potent vasoactive flavonoids and amino acids and clinically efficacious and powerful antioxidants to improve nitric oxide production and endothelial function for superior vascular support.* Consider Tesseract’s proprietary NOX-FLO ™ to nutritionally support patients who are experiencing compromised endothelial function and vascular insufficiencies.
  
  − Tesseract’s CyLoc® and DexKey® delivery technology ensures individual molecules of NOX-FLO™ are delivered directly into the intestinal tract, one by one (the most efficient way). This technology enables us to utilize micro-doses of each ingredient in NOX-FLO™ while still achieving unprecedented bioavailability and efficacy.
  
  − Hesperidin 2S extract’s efficacy in up-regulating endothelial NO production positively impacts endothelial function.* Diosmin beneficially modulates venous tone, prostaglandin synthesis, and lymphatic drainage.*  Clinical research shows CoQ10 supplementation in individuals with vascular insufficiency and other cardiovascular risk factors substantially enhances the bioavailability of nitric oxide, improves flow-mediated dilation, and helps maintain normal systolic and diastolic blood pressure.* A meta-analysis of studies including 300 participants revealed that lipoic acid supplementation significantly increased flow-mediated vasodilation, thereby improving endothelial function.

Read More